iX Biopharma gets SGX nod to list 75.8 million shares in $6m placement

The company entered a placement agreement with OCBC.

iX Biopharma Ltd. has received approval-in-principle from the Singapore Exchange Securities Trading Limited for the listing and quotation of up to 75.8 million new shares under its proposed placement.

The proposed placement is expected to raise gross proceeds of no less than $6m, according to a bourse filing dated 19 February.

The placement agreement was entered into with Oversea-Chinese Banking Corporation Limited. The company had earlier announced the results of the proposed placement on 13 February.

The SGX-ST’s approval-in-principle is subject to compliance with the exchange’s listing requirements and is not to be taken as an indication of the merits of the proposed placement, the company, its subsidiaries or its shares, the company said.

The proposed placement remains subject to the fulfilment of conditions set out in the placement agreement.

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia